Data alert

RITA 3: Benefit of early invasive strategy in moderate-risk unstable angina patients

Final results of RITA 3 (Randomized Intervention Trial of unstable Angina) confirm that an interventional strategy results in a statistically significant reduction in the combined outcome of death, nonfatal myocardial infarction (MI), or refractory angina.1 These trial results provide valuable data on the benefits of an interventional strategy for patients at moderate risk of death from unstable coronary artery disease (CAD). The recent AHA/ACC unstable angina guidelines recommend an invasive strategy for patients at high risk, but specify either an invasive strategy or a conservative strategy for moderate-risk patients.2

DA15.pdf (0.3MB)DA15.pdf (0.3MB)

Data Alert 15 slides.ppt

Download Data%20Alert%2015%20slides.ppt (4 slides - 0.6MB)

Slide 1 Slide 2 Slide 3 Slide 4
Data_Alert.pdf (0.3MB)Data_Alert.pdf (0.3MB)


Related at vwbg.org

Decrease in PAI-1 antigen is greater with ACE inhibition

Plasminogen activator inhibitor-1 (PAI-1) is a known risk factor for cardiovascular (CV) disease and myocardial infarction (MI).

ExTRACT-TIMI 25 study

Results from ExTRACT-TIMI 25: The Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis in Myocardial Infarction Study 25

Results from CRUSADE: Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines

CRUSADE investigated the association between dosing levels of antithrombotic agents and bleeding, in-hospital mortality, and length of stay in patients with NSTE ACS.
More related